Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.120
-0.050 (-4.27%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Inovio Pharmaceuticals Market Cap
Inovio Pharmaceuticals has a market cap or net worth of $92.15 million as of July 16, 2026. Its market cap has increased by 91.97% in one year.
Market Cap
92.15M
Enterprise Value
63.16M
1-Year Change
91.97%
Ranking
Category
Stock Price
$1.12
ChartMarket Cap Chart
Since March 31, 1999, Inovio Pharmaceuticals's market cap has increased from $71.80M to $92.15M, an increase of 28.34%. That is a compound annual growth rate of 0.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 92.15M | -1.13% |
| Dec 31, 2025 | 93.20M | 94.98% |
| Dec 31, 2024 | 47.80M | -65.66% |
| Dec 29, 2023 | 139.20M | -64.23% |
| Dec 30, 2022 | 389.20M | -62.93% |
| Dec 31, 2021 | 1.05B | -29.98% |
| Dec 31, 2020 | 1.50B | 354.33% |
| Dec 31, 2019 | 330.00M | -13.48% |
| Dec 31, 2018 | 381.40M | 2.28% |
| Dec 29, 2017 | 372.90M | -27.45% |
| Dec 30, 2016 | 514.00M | 5.96% |
| Dec 31, 2015 | 485.10M | -12.78% |
| Dec 31, 2014 | 556.20M | -7.96% |
| Dec 31, 2013 | 604.30M | 768.25% |
| Dec 31, 2012 | 69.60M | 27.71% |
| Dec 30, 2011 | 54.50M | -54.51% |
| Dec 31, 2010 | 119.80M | 2.92% |
| Dec 31, 2009 | 116.40M | 408.30% |
| Dec 31, 2008 | 22.90M | -43.18% |
| Dec 31, 2007 | 40.30M | -65.53% |
| Dec 29, 2006 | 116.90M | 163.88% |
| Dec 30, 2005 | 44.30M | -38.64% |
| Dec 31, 2004 | 72.20M | -1.77% |
| Dec 31, 2003 | 73.50M | 440.44% |
| Dec 31, 2002 | 13.60M | -37.04% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 103.72M |
| PolyPid | 99.90M |
| Spero Therapeutics | 98.43M |
| Verrica Pharmaceuticals | 97.23M |
| ImmuCell | 97.07M |
| Pelthos Therapeutics | 94.54M |
| Enlivex | 93.85M |
| Biomea Fusion | 93.27M |